Lippman Evan

Officer, EVP BUSINESS DEVELOPMENT at TEVA

Sold, on record
$2.2M
Dollars the filings state
Form 4 sales
2
Latest Aug 17, 2026
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TEVATEVA PHARMACEUTICAL INDUSTRIES LTDOfficer, EVP BUSINESS DEVELOPMENT

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice TEVANotice
    May 14, 2026 2026

    Filed to sell 41,658 shares ($1.5M)

    Lippman Evan, Officer, EXECUTIVE VP BUSINESS DEVELOPMENT

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale TEVARoutine
    May 14, 2026 same day

    Sold 41,658 shares at $35.58 ($1.5M)

    Lippman Evan, EVP, Business Development

    10b5-1 planSold 48.5% of holdings ($3.1M position)44,191 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice TEVANotice
    Aug 17, 2026 +95 days

    Filed to sell 18,600 shares ($680k)

    Lippman Evan, Officer, EVP BUSINESS DEVELOPMENT

    10b5-1 planFiling

  4. 4 Form 4 sale TEVARoutine
    Aug 17, 2026 same day

    Sold 18,600 shares at $36.57 ($680k)

    Lippman Evan, EVP, Business Development

    10b5-1 planSold 42.1% of holdings ($1.6M position)25,591 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Lippman Evan
Source
Aug 17, 2026Aug 19, 2026TEVAEVP, Business DevelopmentForm 4 sale18,600$680k42.1%RoutineSEC
Aug 17, 2026Aug 17, 2026TEVAOfficer, EVP BUSINESS DEVELOPMENTForm 144 notice18,600$680kNoticeSEC
May 14, 2026May 18, 2026TEVAEVP, Business DevelopmentForm 4 sale41,658$1.5M48.5%RoutineSEC
May 14, 2026May 14, 2026TEVAOfficer, EXECUTIVE VP BUSINESS DEVELOPMENTForm 144 notice41,658$1.5MNoticeSEC